Viking Therapeutics Shares Plunge Amid Mixed Weight-Loss Pill Results
Viking Therapeutics' stock plummeted over 35% after mixed results from its weight-loss drug, which showed significant weight loss but also a high dropout rate due to side effects, leading to investor concern and a sharp decline in share price.